Safety and efficacy of a DKK1 inhibitor (DKN-01) in combination with pembrolizumab (P) in patients (Pts) with advanced gastroesophageal (GE) malignancies

S. J. Klempner; J. Bendell; V. Meucci Villaflor; L. Tenner; S. Stein; C. A. Sirard; W. Newman; M. Kagey; K. Schlienger; J. Strickler

doi:10.1093/annonc/mdy282.044

Safety and efficacy of a DKK1 inhibitor (DKN-01) in combination with pembrolizumab (P) in patients (Pts) with advanced gastroesophageal (GE) malignancies

S. J. Klempner, J. Bendell, V. Meucci Villaflor, L. Tenner, S. Stein, C. A. Sirard, W. Newman, M. Kagey, K. Schlienger, J. Strickler

Mays Cancer Center

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	viii222
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy282.044
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy282.044

Cite this

Klempner, S. J., Bendell, J., Meucci Villaflor, V., Tenner, L., Stein, S., Sirard, C. A., Newman, W., Kagey, M., Schlienger, K., & Strickler, J. (2018). Safety and efficacy of a DKK1 inhibitor (DKN-01) in combination with pembrolizumab (P) in patients (Pts) with advanced gastroesophageal (GE) malignancies. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii222. https://doi.org/10.1093/annonc/mdy282.044

Safety and efficacy of a DKK1 inhibitor (DKN-01) in combination with pembrolizumab (P) in patients (Pts) with advanced gastroesophageal (GE) malignancies. / Klempner, S. J.; Bendell, J.; Meucci Villaflor, V. et al.

In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii222.

Research output: Contribution to journal › Article › peer-review

Klempner, SJ, Bendell, J, Meucci Villaflor, V, Tenner, L, Stein, S, Sirard, CA, Newman, W, Kagey, M, Schlienger, K & Strickler, J 2018, 'Safety and efficacy of a DKK1 inhibitor (DKN-01) in combination with pembrolizumab (P) in patients (Pts) with advanced gastroesophageal (GE) malignancies', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii222. https://doi.org/10.1093/annonc/mdy282.044

Klempner SJ, Bendell J, Meucci Villaflor V, Tenner L, Stein S, Sirard CA et al. Safety and efficacy of a DKK1 inhibitor (DKN-01) in combination with pembrolizumab (P) in patients (Pts) with advanced gastroesophageal (GE) malignancies. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii222. https://doi.org/10.1093/annonc/mdy282.044

@article{482037a71ee4427785ced21456c36fb4,

title = "Safety and efficacy of a DKK1 inhibitor (DKN-01) in combination with pembrolizumab (P) in patients (Pts) with advanced gastroesophageal (GE) malignancies",

author = "Klempner, {S. J.} and J. Bendell and {Meucci Villaflor}, V. and L. Tenner and S. Stein and Sirard, {C. A.} and W. Newman and M. Kagey and K. Schlienger and J. Strickler",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy282.044",

language = "English (US)",

volume = "29",

pages = "viii222",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Safety and efficacy of a DKK1 inhibitor (DKN-01) in combination with pembrolizumab (P) in patients (Pts) with advanced gastroesophageal (GE) malignancies

AU - Klempner, S. J.

AU - Bendell, J.

AU - Meucci Villaflor, V.

AU - Tenner, L.

AU - Stein, S.

AU - Sirard, C. A.

AU - Newman, W.

AU - Kagey, M.

AU - Schlienger, K.

AU - Strickler, J.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85064805430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064805430&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy282.044

DO - 10.1093/annonc/mdy282.044

M3 - Article

C2 - 32136477

VL - 29

SP - viii222

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

ER -

Safety and efficacy of a DKK1 inhibitor (DKN-01) in combination with pembrolizumab (P) in patients (Pts) with advanced gastroesophageal (GE) malignancies

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this